The global EPO Biomarkers market is anticipated to grow at a modest CAGR of around 5.3% during the forecast period. EPO is produced by the kidneys and is a factor responsible for regulating red blood cell (RBC) production in mammals. Some of the EPO biomarkers available in the market are epoetin alfa, epoetin beta, epoetin zeta, epoetin theta, recombinant human erythropoietin, and...